NOVARTIS AG

Forecast & Rating12 analysts currently cover NOVARTIS AG, with about 41.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $156.56, about 13.6% upside from the current price of $137.76. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 64.9% of past price targets were eventually met, which adds credibility. For you, this means institutional views on NOVARTIS AG are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 11, 2026; for reference only and not investment advice.